Evidence map›Paper›PMID 35488330›Full record

Observational studyBMC pulmonary medicine2022

Impact of anxiety and depression on the prognosis of copd exacerbations.

Sandra Martínez-Gestoso, María-Teresa García-Sanz, José-Martín Carreira, Francisco-Javier Salgado, Uxío Calvo-Álvarez, Liliana Doval-Oubiña, Sandra Camba-Matos, Lorena Peleteiro-Pedraza, Miguel-Angel González-Pérez, Pedro Penela-Penela and 2 more

Erratum issuedAbstract readObservational Study
In one paragraph

Observational study in BMC pulmonary medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Depression and Anxiety Among Patients with COPD: A Nationwide Study from Lithuania.International journal of chronic obstructive pulmonary disease · 2026
    Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Sandra Martínez-GestosoEmergencies Department, Salnés Couny Hospital, Vilagarcía de Arousa, Spain.
María-Teresa García-SanzTranslational Research in Airway Diseases Group (TRIAD)-Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. maytegsanz@gmail.com.
José-Martín CarreiraRadiology Department, University of Santiago de Compostela, Santiago de Compostela, Spain.
Francisco-Javier SalgadoTranslational Research in Airway Diseases Group (TRIAD)-Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
Uxío Calvo-ÁlvarezRespiratory Medicine, Arquitecto Marcide Hospital, Ferrol, Spain.
Liliana Doval-OubiñaEmergencies Department, Salnés Couny Hospital, Vilagarcía de Arousa, Spain.
Sandra Camba-MatosEmergencies Department, Salnés Couny Hospital, Vilagarcía de Arousa, Spain.
Lorena Peleteiro-PedrazaUniversity Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.
Miguel-Angel González-PérezPrimary Care, CS Valle-Inclán, Ourense, Spain.
Pedro Penela-PenelaRespiratory Medicine, HM Hospital, Santiago de Compostela, Spain.
Andrés Vilas-IglesiasRespiratory Medicine, HM Hospital, Santiago de Compostela, Spain.
Francisco-Javier González-BarcalaTranslational Research in Airway Diseases Group (TRIAD)-Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFrequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an impact on COPD prognosis. However, they are underdiagnosed and rarely treated properly.

aimTo establish the prevalence of depression and anxiety in patients admitted for Acute Exacerbation of COPD (AECOPD) and determine their influence on COPD prognosis.

methodsProspective observational study conducted from October 1, 2016 to October 1, 2018 at the following centers in Galicia, Spain: Salnés County Hospital, Arquitecto Marcide, and Clinic Hospital Complex of Santiago de Compostela. Patients admitted for AECOPD who agreed to participate and completed the anxiety and depression scale (HADS) were included in the study.

results288 patients (46.8%) were included, mean age was 73.7 years (SD 10.9), 84.7% were male. 67.7% patients were diagnosed with probable depression, and depression was established in 41.7%; anxiety was probable in 68.2% and established in 35.4%. 60.4% of all patients showed symptoms of both anxiety and depression. Multivariate analysis relates established depression with a higher risk of late readmission (OR 2.06, 95% CI 1.28; 3.31) and a lower risk of mortality at 18 months (OR 0.57, 95% CI 0.37; 0.90).

conclusionThe prevalence of anxiety and depression in COPD patients is high. Depression seems to be an independent factor for AECOPD, so early detection and a multidisciplinary approach could improve the prognosis of both entities. The study was approved by the Ethical Committee of Galicia (code 2016/460).

Indexed as

DepressionPulmonary Disease, Chronic ObstructiveAgedAnxietyComorbidityFemaleHumansMalePrognosisAnxietyCOPDDepressionPrognosis

Identifiers

PMID35488330
PMCPMC9052487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.